Mitesco (OTCMKTS:MITI – Get Free Report) and Precipio (NASDAQ:PRPO – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, institutional ownership, valuation, risk, dividends, profitability and analyst recommendations.
Institutional & Insider Ownership
0.0% of Mitesco shares are owned by institutional investors. Comparatively, 10.5% of Precipio shares are owned by institutional investors. 4.9% of Mitesco shares are owned by insiders. Comparatively, 16.6% of Precipio shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Profitability
This table compares Mitesco and Precipio’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Mitesco | -7,638.20% | -2.18% | -2,982.65% |
| Precipio | -3.57% | -6.73% | -4.49% |
Valuation and Earnings
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Mitesco | $40,000.00 | 32.51 | $500,000.00 | ($0.33) | -0.19 |
| Precipio | $24.05 million | 1.67 | -$360,000.00 | ($0.47) | -47.77 |
Mitesco has higher earnings, but lower revenue than Precipio. Precipio is trading at a lower price-to-earnings ratio than Mitesco, indicating that it is currently the more affordable of the two stocks.
Analyst Recommendations
This is a summary of recent ratings and recommmendations for Mitesco and Precipio, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Mitesco | 0 | 0 | 0 | 0 | 0.00 |
| Precipio | 1 | 0 | 0 | 0 | 1.00 |
Volatility and Risk
Mitesco has a beta of 4.88, suggesting that its share price is 388% more volatile than the S&P 500. Comparatively, Precipio has a beta of 1.3, suggesting that its share price is 30% more volatile than the S&P 500.
About Mitesco
Mitesco, Inc. does not have significant operations. Previously, it was engaged in healthcare technology and services business. Mitesco, Inc. is based in Vero Beach, Florida.
About Precipio
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. The company is based in New Haven, Connecticut.
Receive News & Ratings for Mitesco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mitesco and related companies with MarketBeat.com's FREE daily email newsletter.
